Conformationally constrained parathyroid hormone (PTH) analogs

Details for Australian Patent Application No. 2002339843 (hide)

Owner The General Hospital Corporation Gardella, T.

Inventors Gardella, Thomas, J.

Agent Houlihan2

Pub. Number AU-B-2002339843

PCT Number PCT/US02/22922

PCT Pub. Number WO2003/009804

Priority 60/306,866 23.07.01 US; 60/326,212 02.10.01 US

Filing date 19 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 6 December 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 49/00 (2006.01) Preparations for testing

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 5/18 (2006.01) Drugs for disorders of the endocrine system

A61P 5/20 (2006.01) Drugs for disorders of the endocrine system

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

C07K 14/635 (2006.01) Peptides having more than 20 amino acids

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/306,866 23.07.01 US; 60/326,212 02.10.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002339843

6 December 2007 Application Accepted

  Published as AU-B-2002339843

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002339844-SCREENING AND THERAPEUTIC METHODS FOR PROMOTING WAKEFULNESS AND SLEEP

2002339842-A TWO UNIT PORTABLE CELLULAR PHONE SYSTEM